3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow Euvax-B: new trials by email Literature Review of Euvax-B trials Research Report on Euvax-B
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anti-Hep B Antibodies at Age 9 to 10 Years After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine. Euvax B®: Hepatitis B vaccine - Hepatitis B | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 150 | 2016-02-01 | 2022-04-06 |
| DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants DTaP-IPV-Hep B-PRP~T combined vaccine, DTaP-IPV//PRP~T and Hepatitis B vaccine - Diphtheria, Tetanus | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 310 | 2014-03-01 | 2017-04-26 |
| A Phase III Study to Assess the Immunogenicity and Safety of Eutravac (DTap-HB Combined Vaccine) With DTaP and Hepatitis B Vaccines in Healthy Infants Eutravac - Healthy Infants | Phase 3 | Completed | LG Life Sciences | 289 | 2009-08-01 | 2013-07-11 |
Hepatitis B (2) · Diphtheria (1) · Haemophilus Infections (1) · Poliomyelitis (1) · Tetanus (1) · Whooping Cough (1)
Sanofi Pasteur, a Sanofi Company (2) · LG Life Sciences (1)
South Korea (2) · Thailand (1)